DURECT CORP (DRRX)
 
Quote Price $0.80
Price change for today in $ 0.00
Price change for today in % 0.00
Open Price $0.00
Previous Close $0.80
Daily Range $0.00 - $0.00
52-Week Range $0.68 - $3.51
Volume 0
 
 
Brokerage Analyst Recommendations 
2 Brokerage Firms Covering DRRX
 
 
Strong Buy
2 		Buy
0 		Hold
0		 Sell
0		 Strong Sell
0
Average Broker Recommendation (ABR):1 
 
Description
Durect Corp. is pioneering the treatment of chronic diseases and conditions by developing and commercializing pharmaceutical systems to deliver the right drug to the right place in the right amount at the right time. Its pharmaceutical systems combine engineering innovations and delivery technology from the medical device and drug delivery industries with its proprietary pharmaceutical and biotechnology drug formulations.
 
10240 BUBB RD
CUPERTINO, CA
95014, USA
Phone: 4087771417
Fax: 408-777-3577
Web: http://www.durect.com
 Industry:MED-DRUGS
Sector: Medical
Fiscal Year End:December
Last Reported Quarter:03/31/12
Next EPS Date:08/09/12
 
Capital Structure Solvency and Cash Flow
No comments yet. Be the first
make a comment about Capital Structure Solvency and Cash Flow
 
Governance Social Responsibility and Employee Relations
No comments yet. Be the first
make a comment about Governance Social Responsibility and Employee Relations
 
Acquisitions Divestitures and Joint Ventures
No comments yet. Be the first
make a comment about Acquisitions Divestitures and Joint Ventures
 
Recent and Upcoming Events
May 15, 2012 11:11 Biostar Pharmaceuticals is Among the Companies in the Pharmaceuticals Industry With the Lowest P/E Ratio (BSPM, SKBI, DRRX)
May 15, 2012 09:43 DURECT receives four US patents for chronic pain therapy
May 14, 2012 04:26 DURECT reports net income for Q1
May 08, 2012 09:00 Pain Therapeutics Reports Q1 2012 Financial Results
May 04, 2012 21:06 DURECT Corporation (DRRX) Corporate Event Announcement Notice
May 03, 2012 21:07 DURECT Corporation (DRRX) Corporate Event Announcement Notice
May 03, 2012 16:05 DURECT Corporation Announces First Quarter 2012 Financial Results and Update of Programs
May 03, 2012 08:30 Four U.S. Patents Issued for REMOXY
May 03, 2012 08:15 DURECT Announces Issuance of U.S. Patents Covering ORADURA? Technology
Apr 26, 2012 21:07 DURECT Corporation (DRRX) Corporate Event Announcement Notice
Apr 25, 2012 21:02 DURECT Corporation (DRRX) Corporate Event Announcement Notice
Apr 25, 2012 16:15 DURECT Corporation Invites You to Join its First Quarter 2012 Earnings Conference Call
Apr 23, 2012 15:00 Durect Looks to Continue to Trade Below its Annual-Low Share Price Today
Apr 11, 2012 05:56 DURECT receives back US and Canadian rights to pain reliever drug from Hospira
Apr 10, 2012 15:00 Shares of Durect Fall Below Previous 52-Week Low

 
Major Risks
No comments yet. Be the first
make a comment about Major Risks
 


Created by: WikiMigrationBot. Last Modification: Thursday 03 of June, 2010 06:51:27 CDT by WikiMigrationBot.